Kymera
exponential clinical pipeline growth of degraders targeted protein degradation | Kymera
Company
Deck Type
Sector
Industry
Deck date
December 2021
Slide
7 of 105
Related slides by other companies
OmniAb
Results
May 2023
active clinical programs and approved products so | OmniAb
Equillium
Investor Presentation
August 2023
opportunity celiac disease has no approved therapies celiac disease billion dollar annual market opportunity me | Equillium
Equillium
Investor Presentation
February 2024
no approved therapies for celiac disease celiac disease billion dollar annual market opportunity me | Equillium
argenx SE
Investor Presentation
March 2023
steady cadence of data over next several years | argenx SE
Other recent decks by Kymera
See all presentations (7 decks)
Investor Presentation
December 2023
Investor Presentation
November 2023
Investor Presentation
August 2023
Investor Presentation
June 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2023 Slidebook.io